PTEN messenger RNA (PTEN mRNA)

PTEN mRNA is the transcribed messenger RNA from the phosphatase and tensin homolog (PTEN) gene. It encodes the PTEN protein, a critical tumor suppressor regulating cell proliferation, survival, and apoptosis as the main negative regulator of the PI3K/Akt pathway[1][4][5]. The amount and activity of PTEN mRNA is dynamically controlled by various transcriptional regulators (such as p53, PPARγ, EGR1) and extensively regulated post-transcriptionally by a large network of microRNAs (e.g., miR-21, miR-19, and many others)[2][4][6]. PTEN mRNA also interacts with long noncoding RNAs (e.g., PTENP1, PTENpg1), which can fine-tune PTEN protein levels via competing endogenous RNA mechanisms or epigenetic modifications[2][6]. Aberrant expression or regulation of PTEN mRNA leads to loss of PTEN protein, frequently associated with oncogenic transformation and inherited syndromes[1][5][7]. PTEN mRNA itself is not a standard therapeutic target (compared to protein, receptor, or enzyme targets), but research into RNA-based strategies is ongoing in molecular oncology. Important context: - PTEN mRNA is not itself a canonical drug target like a protein, receptor, or enzyme. It is a transcript encoding the target (PTEN protein) which is the actual focus of drug development efforts. - is_incorrect: true because “PTEN mRNA” as a drug target is nonstandard and may represent a mis-specification in pharmacological classification systems. The preferred target for therapeutic intervention is the PTEN protein, not its mRNA transcript. If your data schema aims to catalog standard drug targets (receptor, enzyme, transporter, etc.), you should instead reference “Phosphatase and tensin homolog (PTEN)” as the canonical entry[1][3][4][5][7]. If you require information about the PTEN protein as a therapeutic target, that can be provided separately.

Other names

PTEN transcriptPTEN gene transcript

Not applicable directly; experimental mechanisms include: miRNA inhibition (restoring PTEN expression), Antisense oligonucleotides or small molecules targeting PTEN mRNA regulatory elements